Description

Zolpidem Tartrate 10mg Film-Coated Tablets (Psycogen) are specially formulated for the short-term treatment of insomnia, including difficulty falling asleep, frequent night waking, and early morning awakenings. Each film-coated tablet contains 10mg of zolpidem tartrate, a non-benzodiazepine hypnotic that works by acting on the brain’s GABA receptors to induce calmness and sleep.

Manufactured under the Psycogen brand, these tablets are fast-acting and designed to help individuals get to sleep quickly,https://relaxmeds.shop/ stay asleep longer, and wake feeling more refreshed. https://www.medicines.org.uk/emc/product/3975/smp The film coating ensures smoother swallowing and quicker absorption Zolpidem Tartrate.

Key Benefits:

• Helps initiate and maintain sleep

• Fast-acting with minimal next-day drowsiness

• Ideal for short-term use in insomnia Zolpidem Tartrate

• Film-coated for easy oral use and rapid absorption Zolpidem Tartrate

Dosage & Usage: Take one tablet orally with water just before bedtime. Ensure at least 7–8 hours of sleep time. Do not mix with alcohol or other sedatives.

Warning: Zolpidem may cause drowsiness, dizziness, or memory issues. Use only as directed. Habit-forming with prolonged use.

Note: Not recommended during pregnancy, for elderly without dose adjustment, or for people with respiratory conditions unless approved by a doctor.

Mechanism of Action:

Zolpidem enhances the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. By selectively binding to the omega-1 (BZ1) subtype of the GABA-A receptor, it promotes sedation and sleep induction. Unlike benzodiazepines, zolpidem has minimal anxiolytic, muscle relaxant,https://relaxmind.relaxmeds.shop or anticonvulsant properties at therapeutic doses.

---

Indications:

• Short-term treatment of insomnia

  • Difficulty initiating sleep (sleep-onset insomnia)

  • Occasionally prescribed off-label for other sleep-related issues

Note: It is not intended for chronic use due to risks of tolerance, dependence, and side effects.

---

Dosage and Administration:

• Standard Adult Dose: 10 mg taken once nightly immediately before bedtime Zolpidem Tartrate

• Route: Oral

• Administration Guidelines:

  • Should be taken on an empty stomach

  • Ensure at least 7–8 hours are available for sleep after taking the drug

  • Do not take unless able to stay in bed and complete a full night’s sleep

Special Populations:

• Elderly or debilitated patients: Recommended starting dose is 5 mg due to increased sensitivity

• Hepatic impairment: Lower doses recommended

---

Side Effects:

Common:

• Drowsiness

• Dizziness

• Headache

• Diarrhea

Serious (rare but important):

• Complex sleep-related behaviors (e.g., sleep-driving, sleepwalking)

• Memory loss or confusion

• Depression or worsening of mental health

• Allergic reactions (rash, swelling, difficulty breathing) https://relaxmeds.shop/

---

Warnings and Precautions:

• Dependence and abuse potential: Use only as directed; prolonged use can lead to physical and psychological dependence.

• Withdrawal symptoms: Abrupt discontinuation may cause withdrawal effects (e.g., anxiety, agitation, rebound insomnia).

• Next-day impairment: Especially with higher doses or inadequate sleep time.

• Avoid alcohol or other CNS depressants: Increases risk of sedation and respiratory depression.https://relaxmind.relaxmeds.shop.

---

Contraindications:

• Known hypersensitivity to zolpidem or any of its components

• History of complex sleep behaviors after taking zolpidem

---

Drug Interactions:

• CNS depressants (e.g., benzodiazepines, opioids, alcohol)

• CYP3A4 inhibitors/inducers (affect metabolism of zolpidem)

• SSRIs, antipsychotics, and other psychoactive drugs may interact

---

Storage:

• Store at room temperature (20° to 25°C / 68° to 77°F)

• Keep away from light and moisture

• Keep out of reach of children

---

Additional Notes:

• Zolpidem is a Schedule IV controlled substance in the U.S.

• Should not be used by patients with a history of substance abuse

• Not approved for use in children

• Patients should be monitored for cognitive or behavioral changes